Logo image of CRWD

CROWDSTRIKE HOLDINGS INC - A (CRWD) Stock Fundamental Analysis

USA - NASDAQ:CRWD - US22788C1053 - Common Stock

448.24 USD
+3.26 (+0.73%)
Last: 9/17/2025, 10:30:08 AM
Fundamental Rating

4

Taking everything into account, CRWD scores 4 out of 10 in our fundamental rating. CRWD was compared to 280 industry peers in the Software industry. The financial health of CRWD is average, but there are quite some concerns on its profitability. CRWD is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CRWD had positive earnings in the past year.
CRWD had a positive operating cash flow in the past year.
In the past 5 years CRWD reported 4 times negative net income.
CRWD had a positive operating cash flow in each of the past 5 years.
CRWD Yearly Net Income VS EBIT VS OCF VS FCFCRWD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

CRWD has a Return On Assets of -3.20%. This is comparable to the rest of the industry: CRWD outperforms 49.64% of its industry peers.
CRWD has a Return On Equity of -7.91%. This is comparable to the rest of the industry: CRWD outperforms 49.64% of its industry peers.
Industry RankSector Rank
ROA -3.2%
ROE -7.91%
ROIC N/A
ROA(3y)-0.84%
ROA(5y)-2.48%
ROE(3y)-3.08%
ROE(5y)-8.55%
ROIC(3y)N/A
ROIC(5y)N/A
CRWD Yearly ROA, ROE, ROICCRWD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

1.3 Margins

CRWD has a Gross Margin of 74.16%. This is in the better half of the industry: CRWD outperforms 63.21% of its industry peers.
CRWD's Gross Margin has been stable in the last couple of years.
CRWD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y1.2%
CRWD Yearly Profit, Operating, Gross MarginsCRWD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150 -200

6

2. Health

2.1 Basic Checks

CRWD does not have a ROIC to compare to the WACC, probably because it is not profitable.
CRWD has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CRWD has been increased compared to 5 years ago.
CRWD has a better debt/assets ratio than last year.
CRWD Yearly Shares OutstandingCRWD Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
CRWD Yearly Total Debt VS Total AssetsCRWD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 12.68 indicates that CRWD is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 12.68, CRWD belongs to the best of the industry, outperforming 89.64% of the companies in the same industry.
The Debt to FCF ratio of CRWD is 0.72, which is an excellent value as it means it would take CRWD, only 0.72 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.72, CRWD is in the better half of the industry, outperforming 76.07% of the companies in the same industry.
A Debt/Equity ratio of 0.20 indicates that CRWD is not too dependend on debt financing.
CRWD has a Debt to Equity ratio (0.20) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 0.72
Altman-Z 12.68
ROIC/WACCN/A
WACC10.98%
CRWD Yearly LT Debt VS Equity VS FCFCRWD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

CRWD has a Current Ratio of 1.88. This is a normal value and indicates that CRWD is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.88, CRWD perfoms like the industry average, outperforming 59.29% of the companies in the same industry.
CRWD has a Quick Ratio of 1.88. This is a normal value and indicates that CRWD is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CRWD (1.88) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.88
CRWD Yearly Current Assets VS Current LiabilitesCRWD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

8

3. Growth

3.1 Past

The earnings per share for CRWD have decreased by -3.21% in the last year.
Measured over the past years, CRWD shows a very strong growth in Earnings Per Share. The EPS has been growing by 79.46% on average per year.
CRWD shows a strong growth in Revenue. In the last year, the Revenue has grown by 23.46%.
Measured over the past years, CRWD shows a very strong growth in Revenue. The Revenue has been growing by 52.37% on average per year.
EPS 1Y (TTM)-3.21%
EPS 3Y79.46%
EPS 5YN/A
EPS Q2Q%-10.58%
Revenue 1Y (TTM)23.46%
Revenue growth 3Y39.65%
Revenue growth 5Y52.37%
Sales Q2Q%21.28%

3.2 Future

The Earnings Per Share is expected to grow by 20.63% on average over the next years. This is a very strong growth
CRWD is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.01% yearly.
EPS Next Y-8.71%
EPS Next 2Y10.62%
EPS Next 3Y16.74%
EPS Next 5Y20.63%
Revenue Next Year21.83%
Revenue Next 2Y21.74%
Revenue Next 3Y21.65%
Revenue Next 5Y22.01%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CRWD Yearly Revenue VS EstimatesCRWD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 5B 10B 15B
CRWD Yearly EPS VS EstimatesCRWD Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 10 15 20

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 123.82, CRWD can be considered very expensive at the moment.
CRWD's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 27.20. CRWD is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 93.21, the valuation of CRWD can be described as expensive.
CRWD's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.71, CRWD is valued quite expensively.
Industry RankSector Rank
PE 123.82
Fwd PE 93.21
CRWD Price Earnings VS Forward Price EarningsCRWD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as CRWD.
Industry RankSector Rank
P/FCF 108.38
EV/EBITDA N/A
CRWD Per share dataCRWD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

A more expensive valuation may be justified as CRWD's earnings are expected to grow with 16.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.62%
EPS Next 3Y16.74%

0

5. Dividend

5.1 Amount

CRWD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CROWDSTRIKE HOLDINGS INC - A

NASDAQ:CRWD (9/17/2025, 10:30:08 AM)

448.24

+3.26 (+0.73%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-27 2025-08-27/amc
Earnings (Next)11-24 2025-11-24/amc
Inst Owners73.28%
Inst Owner Change3.71%
Ins Owners3.07%
Ins Owner Change-0.92%
Market Cap112.49B
Analysts76.07
Price Target468.28 (4.47%)
Short Float %2.87%
Short Ratio2.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.62%
Min EPS beat(2)9.3%
Max EPS beat(2)9.95%
EPS beat(4)4
Avg EPS beat(4)12.71%
Min EPS beat(4)9.3%
Max EPS beat(4)18.62%
EPS beat(8)8
Avg EPS beat(8)9.93%
EPS beat(12)12
Avg EPS beat(12)12.73%
EPS beat(16)16
Avg EPS beat(16)20.56%
Revenue beat(2)0
Avg Revenue beat(2)-1.13%
Min Revenue beat(2)-2%
Max Revenue beat(2)-0.26%
Revenue beat(4)2
Avg Revenue beat(4)-0.23%
Min Revenue beat(4)-2%
Max Revenue beat(4)0.82%
Revenue beat(8)2
Avg Revenue beat(8)-0.57%
Revenue beat(12)3
Avg Revenue beat(12)-0.49%
Revenue beat(16)7
Avg Revenue beat(16)0.28%
PT rev (1m)-2.27%
PT rev (3m)10.56%
EPS NQ rev (1m)3.29%
EPS NQ rev (3m)-16.37%
EPS NY rev (1m)0.07%
EPS NY rev (3m)2.48%
Revenue NQ rev (1m)-0.96%
Revenue NQ rev (3m)0.08%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)0.27%
Valuation
Industry RankSector Rank
PE 123.82
Fwd PE 93.21
P/S 25.91
P/FCF 108.38
P/OCF 81
P/B 29.94
P/tB 41.27
EV/EBITDA N/A
EPS(TTM)3.62
EY0.81%
EPS(NY)4.81
Fwd EY1.07%
FCF(TTM)4.14
FCFY0.92%
OCF(TTM)5.53
OCFY1.23%
SpS17.3
BVpS14.97
TBVpS10.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.2%
ROE -7.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.16%
FCFM 23.91%
ROA(3y)-0.84%
ROA(5y)-2.48%
ROE(3y)-3.08%
ROE(5y)-8.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y1.2%
F-Score3
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 0.72
Debt/EBITDA N/A
Cap/Depr 143.34%
Cap/Sales 8.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.88
Quick Ratio 1.88
Altman-Z 12.68
F-Score3
WACC10.98%
ROIC/WACCN/A
Cap/Depr(3y)197.98%
Cap/Depr(5y)189.45%
Cap/Sales(3y)9.2%
Cap/Sales(5y)8.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.21%
EPS 3Y79.46%
EPS 5YN/A
EPS Q2Q%-10.58%
EPS Next Y-8.71%
EPS Next 2Y10.62%
EPS Next 3Y16.74%
EPS Next 5Y20.63%
Revenue 1Y (TTM)23.46%
Revenue growth 3Y39.65%
Revenue growth 5Y52.37%
Sales Q2Q%21.28%
Revenue Next Year21.83%
Revenue Next 2Y21.74%
Revenue Next 3Y21.65%
Revenue Next 5Y22.01%
EBIT growth 1Y-638.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year49.75%
EBIT Next 3Y37.89%
EBIT Next 5Y36.81%
FCF growth 1Y29.99%
FCF growth 3Y34.28%
FCF growth 5Y143.57%
OCF growth 1Y30.79%
OCF growth 3Y33.96%
OCF growth 5Y69.1%